Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 09 Jun 2023

Dyslipidemia in diffuse large B-cell lymphoma based on the genetic subtypes: a single-center study of 259 Chinese patients

in Hematologic Malignancies

Yi Xu
Huafei Shen
Yuanfei Shi
Yanchun Zhao
Xiaolong Zhen
Jianai Sun
Xueying Li
De Zhou
Chunmei Yang
Jinhan Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1172623

2,322 views
2 citations

Review

Published on 09 Jun 2023

Myeloproliferative neoplasms – blurring the lines between cancer and chronic inflammatory disorder

in Hematologic Malignancies

Eli M. Soyfer
Angela G. Fleischman

Frontiers in Oncology

doi 10.3389/fonc.2023.1208089

9,061 views
5 citations

Editorial

Published on 09 Jun 2023

Editorial: Real-world data and real-world evidence in hematologic malignancies

in Hematologic Malignancies

Michele Malagola
Robert Ohgami
Raffaella Greco

Frontiers in Oncology

doi 10.3389/fonc.2023.1232980

1,592 views

Case Report

Published on 08 Jun 2023

Case Report: Effects of multiple myeloma therapy on essential thrombocythemia and vice versa: a case of synchronous dual hematological malignancy

in Hematologic Malignancies

Nupur Krishnan
Russell Price
Rouslan Kotchetkov

Frontiers in Oncology

doi 10.3389/fonc.2023.1213942

2,625 views
2 citations

Original Research

Published on 08 Jun 2023

Development and validation of platelet-to-albumin ratio as a clinical predictor for diffuse large B-cell lymphoma

in Hematologic Malignancies

Jinghan Wang
Linjie Li
Fang Yu
Junyu Zhang
Liping Mao
Bocheng Chen
Xuelian Hu
Hongmei Zhou
Wanzhuo Xie
Hongyan Tong

Frontiers in Oncology

doi 10.3389/fonc.2023.1138284

2,402 views
4 citations

Original Research

Published on 08 Jun 2023

Immune cell proportions correlate with clinicogenomic features and ex vivo drug responses in acute myeloid leukemia

in Hematologic Malignancies

Kyle A. Romine
Daniel Bottomly
William Yashar
Nicola Long
Matthew Viehdorfer
Shannon K. McWeeney
Jeffrey W. Tyner

Frontiers in Oncology

doi 10.3389/fonc.2023.1192829

1,932 views
1 citation

Case Report

Published on 07 Jun 2023

Case Report: Avelumab and ruxolitinib to manage polycythemia vera and secondary metastatic Merkel cell carcinoma: a possible successful combination

in Hematologic Malignancies

Chiara Masucci
Mauro Passucci
Emilia Scalzulli
Ida Carmosino
Marcello Capriata
Alessandro Costa
Claudia Ielo
Maurizio Martelli
Massimo Breccia

Frontiers in Oncology

doi 10.3389/fonc.2023.1212638

1,941 views

Correction

Published on 06 Jun 2023

Corrigendum: Interpreting flow cytometry with caution: a case report of follicular lymphoma in leukemic phase misdiagnosed as chronic lymphocytic leukemia

in Hematologic Malignancies

Yuan Ren
Congwei Jia
Miao Chen
Wei Wang
Wei Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1229649

996 views

Original Research

Published on 05 Jun 2023

Identification of aberrantly expressed lncRNAs and ceRNA networks in multiple myeloma: a combined high-throughput sequencing and microarray analysis

in Hematologic Malignancies

Min-Qiu Lu
Yu-Qin He
Yin Wu
Hui-Xing Zhou
Yuan Jian
Wen Gao
Li Bao
Wen-Ming Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1160342

2,292 views
3 citations

Original Research

Published on 05 Jun 2023

Phenotyping of lymphoproliferative tumours generated in xenografts of non-small cell lung cancer

in Hematologic Malignancies

David R. Pearce
Ayse U. Akarca
Roel P. H. De Maeyer
Emily Kostina
Ariana Huebner
Monica Sivakumar
Takahiro Karasaki
Kavina Shah
Sam M. Janes
Nicholas McGranahan

Frontiers in Oncology

doi 10.3389/fonc.2023.1156743

4,147 views
6 citations

Original Research

Published on 02 Jun 2023

Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study

in Hematologic Malignancies

Zahra Haider
Tove Wästerlid
Linn Deleskog Spångberg
Leily Rabbani
Cecilia Jylhä
Birna Thorvaldsdottir
Aron Skaftason
Hero Nikdin Awier
Aleksandra Krstic
Anna Gellerbring

Frontiers in Oncology

doi 10.3389/fonc.2023.1176698

5,358 views
5 citations

Original Research

Published on 31 May 2023

Validity of Italian administrative healthcare data in describing the real-world utilization of infusive antineoplastic drugs: the study case of rituximab use in patients treated at the University Hospital of Siena for onco-haematological indications

in Hematologic Malignancies

Claudia Bartolini
Giuseppe Roberto
Anna Girardi
Valentino Moscatelli
Andrea Spini
Alessandro Barchielli
Monica Bocchia
Alberto Fabbri
Sandra Donnini
Marina Ziche

Frontiers in Oncology

doi 10.3389/fonc.2023.1059109

1,739 views
1 citation

Brief Research Report

Published on 29 May 2023

The pro-tumorigenic cytokine IL-32 has a high turnover in multiple myeloma cells due to proteolysis regulated by oxygen-sensing cysteine dioxygenase and deubiquitinating enzymes

in Hematologic Malignancies

Martin Kastnes
Kristin Roseth Aass
Siri Anshushaug Bouma
Charlotte Årseth
Muhammad Zahoor
Mariia Yurchenko
Therese Standal

Frontiers in Oncology

doi 10.3389/fonc.2023.1197542

2,763 views
3 citations

Case Report

Published on 25 May 2023

TFG::ALK fusion in ALK positive large B-cell lymphoma: a case report and review of literature

in Hematologic Malignancies

Andrew Xiao
Nahid Shahmarvand
Alexandra Nagy
Jyoti Kumar
Jessica Van Ziffle
Patrick Devine
Franklin Huang
Lhara Lezama
Peng Li
Robert S. Ohgami

Frontiers in Oncology

doi 10.3389/fonc.2023.1174606

2,950 views
1 citation

Original Research

Published on 25 May 2023

Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma

in Hematologic Malignancies

Katia Mancuso
Elena Zamagni
Vincenza Solli
Liliana Gabrielli
Marta Leone
Lucia Pantani
Serena Rocchi
Ilaria Rizzello
Paola Tacchetti
Stefano Ghibellini

Frontiers in Oncology

doi 10.3389/fonc.2023.1208741

2,304 views
6 citations

Review

Published on 24 May 2023

Tackling the dysregulated immune-checkpoints in classical Hodgkin lymphoma: bidirectional regulations between the microenvironment and Hodgkin/Reed-Sternberg cells

in Hematologic Malignancies

Alessandro Cellini
Federico Scarmozzino
Francesco Angotzi
Edoardo Ruggeri
Angelo Paolo Dei Tos
Livio Trentin
Marco Pizzi
Andrea Visentin

Frontiers in Oncology

doi 10.3389/fonc.2023.1203470

2,866 views
6 citations